GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,588.40p
   
  • Change Today:
      4.00p
  • 52 Week High: 1,621.60
  • 52 Week Low: 1,418.00
  • Currency: UK Pounds
  • Shares Issued: 4,987.96m
  • Volume: 5,651,160
  • Market Cap: 79,229m
  • RiskGrade: 74
  • Beta: 0.00

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.0% 504.9%
Div Cover 1.5 1.4
Op Mrgn 17.8% 23.6%
ROCE 64.2%  
Latest F'cast
P/E 13.3 1442.2
PEG 2.0 n/a
Pr/Revenue 2.6 2.5
Pr/Book 21.6  
Latest F'cast
Revenue 2.1% 3.1%
PBT 36.2% 56.5%
EPS 6.8% -99.1%
DPS n/a -99.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 31,784.25 7,513.11 1.10p 1,442.2 n/a -99% 0.80p 504.9%
31-Dec-20 34,528.04 8,196.94 1.15p 1,384.6 0.2 +4% 0.80p 505.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 12-Jun-2019 17:10 RNS
FDA approval for Nucala self-administration 07-Jun-2019 07:00 RNS
CHMP positive on GSK's Nucala self-administration 04-Jun-2019 08:00 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Jun-19 Transfer From Emma Walmsley 0.000p 7 0.00
11-Jun-19 Buy Emma Walmsley 1,584.80p 7 110.94
10-May-19 Transfer From Emma Walmsley 0.000p 9 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,588.40p
Change Today 4.00p
% Change 0.25 %
52 Week High 1,621.60
52 Week Low 1,418.00
Volume 5,651,160
Shares Issued 4,987.96m
Market Cap 79,229m
Beta 0.00
RiskGrade 74

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.22% below the market average63.22% below the market average63.22% below the market average63.22% below the market average63.22% below the market average
48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average
Price Trend
33.33% above the market average33.33% above the market average33.33% above the market average33.33% above the market average33.33% above the market average
27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average
Income
62.14% above the market average62.14% above the market average62.14% above the market average62.14% above the market average62.14% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
8.77% above the market average8.77% above the market average8.77% above the market average8.77% above the market average8.77% above the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 12
Sell 0
Strong Sell 1
Total 17
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-19 21-Feb-19
Paid 11-Jul-19 11-Apr-19
Amount 19.00p 23.00p

Trades for 17-Jun-2019

Time Volume / Share Price
16:35 50,000 @ 1,588.40p
16:35 14,403 @ 1,588.40p
16:35 2,335,333 @ 1,588.40p
16:29 138 @ 1,588.00p
16:29 179 @ 1,588.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page